877-269-7890 from 8 AM - 10 PM ET
877-269-7890 from 8 AM - 10 PM ET
Issue Laboratoire Riva Inc. is recalling one lot (lot C9323) of Riva-Risperidone 0.25 mg tablets due to a packaging error. Some bottles may incorrectly contain only Riva-Gabapentin 100 mg capsules. Pharmacists may not recognize the error and inadvertently repackage and dispense pill bottles that contain the wrong medication.
Risperidone is a prescription drug used in adults to treat the symptoms of schizophrenia and related psychotic disorders, as well as bipolar disorder. It may also be used for the short-term treatment of severe dementia related to Alzheimer's disease.
Gabapentin is a prescription drug used for treating epilepsy (seizures).
If you miss a dose of Risperidone, you may not have proper control of your condition or its symptoms may worsen.
By taking Gabapentin instead of Risperidone, you may:
If you notice any of these signs or symptoms, contact your health care professional immediately.
Riva-Risperidone 0.25 mg tablets are yellowish-orange, oblong-shaped coated tablets, with "0.25" on one side and "R" on the other side. Riva-Gabapentin 100 mg capsules are white hard gelatin capsules, with "Gabapentin / 100 mg" printed on the capsule in blue ink.
Health Canada is monitoring the company's recall. If additional safety information is identified, Health Canada will take appropriate action and inform Canadians as needed.
Riva-Risperidone 0.25 mg tablets 100-tablet bottles
Additional information for health professionals:
Également disponible en français
For further information: Media Enquiries: Health Canada, (613) 957-2983, [email protected]; Public Enquiries: (613) 957-2991, 1-866 225-0709, [email protected]
NOTICE TO THE MEDIA - Government of Canada to announce funding to ...
Government of Canada partners with community-based organizations...
Health Canada announces new regulations for supplemented foods...
Statement - The Government of Canada and industry continue to...
Government of Canada transfers land on the west side of Batoche...
MEDIA ADVISORY - Parks Canada and the Métis Nation-Saskatchewan...
877-269-7890 from 8 AM - 10 PM ET